Search Results - "Rieger, J. M."

Refine Results
  1. 1

    The relationship between lingual and hypoglossal nerve function and quality of life in head and neck cancer by Elfring, T., Boliek, C. A., Winget, M., Paulsen, C., Seikaly, H., Rieger, J. M.

    Published in Journal of oral rehabilitation (01-02-2014)
    “…Summary Sensorimotor impairment of the tongue has the potential to affect speech and swallowing. The purpose of this study was to critically examine the…”
    Get full text
    Journal Article
  2. 2

    Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis by CAVALCANTE, I. C, CASTRO, M. V, RIBEIRO, R. A, BRITO, G. A. C, BARRETO, A. R. F, SULLIVAN, G. W, VALE, M, ALMEIDA, P. R. C, LINDEN, J, RIEGER, J. M, CUNHA, F. Q, GUERRANT, R. L

    Published in Infection and Immunity (01-05-2006)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature by Rieger, J.M., Zalmanowitz, J.G., Wolfaardt, J.F.

    “…The use of radiation therapy and/or chemotherapy in advanced head and neck cancer is increasing in popularity, driven by the notion that sparing the organs of…”
    Get full text
    Journal Article
  4. 4

    Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow–derived cells or deletion of the A2A receptor on non-bone marrow–derived cells by Li, Y., Oskouian, R.J., Day, Y.-J., Rieger, J.M., Liu, L., Kern, J.A., Linden, J.

    Published in Neuroscience (2006)
    “…Activation of the adenosine A2A receptor (A2AR) at the time of reperfusion has been shown to reduce ischemia–reperfusion injury in peripheral tissues and…”
    Get full text
    Journal Article
  5. 5

    A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence by Alam, M S, Kurtz, C C, Wilson, J M, Burnette, B R, Wiznerowicz, E B, Ross, W G, Rieger, J M, Figler, R A, Linden, J, Crowe, S E, Ernst, P B

    Published in Mucosal immunology (01-05-2009)
    “…Helicobacter pylori causes a lifelong infection and provides a model of bacterial adaptation and persistent colonization. Adenosine is an anti-inflammatory…”
    Get full text
    Journal Article
  6. 6

    Establishing a reliable protocol to measure tongue sensation by BOLIEK, C. A., RIEGER, J. M., LI, S. Y. Y., MOHAMED, Z., KICKHAM, J., AMUNDSEN, K.

    Published in Journal of oral rehabilitation (01-06-2007)
    “…summary  The relationship between tongue sensation and tongue function for speech, mastication and deglutition are growing areas of interest among…”
    Get full text
    Journal Article
  7. 7

    The effect of automatic speech recognition systems on speaking workload and task efficiency by RIEGER, J. M.

    Published in Disability and rehabilitation (01-02-2003)
    “…Purpose :This investigation explored the speech-production behaviors associated with the use of automatic speech recognition (ASR) software for dictation of…”
    Get full text
    Journal Article
  8. 8

    Sensory outcomes of the anterior tongue after lingual nerve repair in oropharyngeal cancer by ELFRING, T. T., BOLIEK, C. A., SEIKALY, H., HARRIS, J., RIEGER, J. M.

    Published in Journal of oral rehabilitation (01-03-2012)
    “…Summary  Primary treatment of oropharyngeal cancer often involves surgical resection and reconstruction of the affected area. However, during base of tongue…”
    Get full text
    Journal Article
  9. 9

    Design, Synthesis, and Evaluation of Novel A2A Adenosine Receptor Agonists by Rieger, Jayson M, Brown, Milton L, Sullivan, Gail W, Linden, Joel, Macdonald, Timothy L

    Published in Journal of medicinal chemistry (15-02-2001)
    “…We have been interested in the design, synthesis, and evaluation of novel adenosine A2A agonists. Through the use of comparative molecular field analysis…”
    Get full text
    Journal Article
  10. 10

    Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists by Sullivan, G W, Rieger, J M, Scheld, W M, Macdonald, T L, Linden, J

    Published in British journal of pharmacology (01-03-2001)
    “…Novel 2-propynylcyclohexyl-5'-N:-ehtylcarboxamidoadenosines, trans-substituted in the 4-position of the cyclohexyl ring, were evaluated in binding assays to…”
    Get full text
    Journal Article
  11. 11

    A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion by Okusa, M D, Linden, J, Huang, L, Rieger, J M, Macdonald, T L, Huynh, L P

    “…We sought to determine the mechanisms responsible for the reduced renal tissue injury by agonists of A(2A) adenosine receptors (A(2A)-ARs) in models of…”
    Get more information
    Journal Article
  12. 12

    Effect of Novel A[subscript 2A] Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis by Cavalcante, I. C, Castro, M. V, Barreto, A. R. F, Sullivan, G. W, Vale, M, Almeida, P. R. C, Linden, J, Rieger, J. M, Cunha, F. Q, Guerrant, R. L, Ribeiro, R. A, Brito, G. A. C

    Published in Infection and immunity (01-05-2006)
    “…Clostridium difficile is a spore-forming, anaerobic, gram-positive bacillus that releases two main virulence factors: toxins A and B. Toxin A plays an…”
    Get full text
    Journal Article
  13. 13

    Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model by McPherson, J A, Barringhaus, K G, Bishop, G G, Sanders, J M, Rieger, J M, Hesselbacher, S E, Gimple, L W, Powers, E R, Macdonald, T, Sullivan, G, Linden, J, Sarembock, I J

    “…Endothelial activation and leukocyte recruitment are early events in atherosclerosis and the vascular response to injury. Adenosine has anti-inflammatory…”
    Get full text
    Journal Article
  14. 14

    Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation by Peirce, S M, Skalak, T C, Rieger, J M, Macdonald, T L, Linden, J

    “…Activation of A(2A) adenosine receptors (A(2A)-AR) by ATL-146e (formerly DWH-146e) prevents inflammatory cell activation and adhesion. Recurrent…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Comparative molecular field analysis of colchicine inhibition and tubulin polymerization for combretastatins binding to the colchicine binding site on beta-tubulin by Brown, M L, Rieger, J M, Macdonald, T L

    Published in Bioorganic & medicinal chemistry (01-06-2000)
    “…A molecular modeling study using Comparative Molecular Field Analysis (CoMFA) was undertaken to develop a predictive model for combretastatin binding to the…”
    Get full text
    Journal Article
  17. 17

    Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion by Cassada, David C., Tribble, Curtis G., Kaza, Aditya K., Fiser, Steven M., Long, Stewart M., Linden, Joel, Rieger, Jayson M., Kron, Irving L., Kern, John A.

    Published in Surgery (01-08-2001)
    “…Background. We hypothesized that inflammation during spinal cord reperfusion worsens ischemic injury. ATL-146e, an adenosine A2A agonist with known…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Mouse spinal cord compression injury is reduced by either activation of the adenosine A sub(2A) receptor on bone marrow-derived cells or deletion of the A sub(2A) receptor on non-bone marrow-derived cells by Li, Y, Oskouian, R J, Day, Y-J, Rieger, J M, Liu, L, Kern, JA, Linden, J

    Published in Neuroscience (01-01-2006)
    “…Activation of the adenosine A sub(2A) receptor (A sub(2A)R) at the time of reperfusion has been shown to reduce ischemia-reperfusion injury in peripheral…”
    Get full text
    Journal Article
  19. 19

    Effect of Novel A sub(2A) Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis by Cavalcante, I C, Castro, M V, Barreto, ARF, Sullivan, G W, Vale, M, Almeida, PRC, Linden, J, Rieger, J M, Cunha, F Q, Guerrant, R L, Ribeiro, R A, Brito, GAC

    Published in Infection and immunity (01-05-2006)
    “…Clostridium difficile is a spore-forming, anaerobic, gram-positive bacillus that releases two main virulence factors: toxins A and B. Toxin A plays an…”
    Get full text
    Journal Article
  20. 20

    Effect of Novel A 2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis by Cavalcante, I. C., Castro, M. V., Barreto, A. R. F., Sullivan, G. W., Vale, M., Almeida, P. R. C., Linden, J., Rieger, J. M., Cunha, F. Q., Guerrant, R. L., Ribeiro, R. A., Brito, G. A. C.

    Published in Infection and immunity (01-05-2006)
    “…ABSTRACT Clostridium difficile is a spore-forming, anaerobic, gram-positive bacillus that releases two main virulence factors: toxins A and B. Toxin A plays an…”
    Get full text
    Journal Article